Department of Clinical Pharmacy
College of Pharmacy, and
Professor of Medicine
Division of Infectious Disease
College of Medicine
Medical University of South Carolina
Click to view Dr. Bosso's biography
His research interests focus on anti-infective pharmacokinetics, pharmacodynamics, and efficacy in both pediatric and adult patients. Dr. Bosso has published articles in Pharmacotherapy, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, The Pediatric Infectious Disease Journal, Diagnostic Microbiology and Infectious Disease, Clinical Infectious Diseases, and The Journal of Infectious Diseases Pharmacotherapy. He has written chapters for textbooks that include Pharmacotherapy: A Pathophysiologic Approach, The Pharmacotherapy Self-Assessment Program, and The Textbook of Pediatric Infectious Diseases. He is a member of the editorial boards of Antimicrobial Agents and Chemotherapy, Pharmacotherapy, and The Journal of Pediatric Pharmacology and Therapeutics.
Dr. Bosso has been active in a number of professional organizations, and was a founding member and a past-president of the Society of Infectious Diseases Pharmacists, and a past-president of the American College of Clinical Pharmacy.
Eileen Carter, PhD, RN
Assistant Professor of Nursing
Columbia School of Nursing and
New York – Presbyterian Hospital
New York, NY
Click to view Dr. Carter's biography
Dr. Carter received the Mary Fay Enrichment Award at Brigham and Women’s Hospital in 2009 and was named Jonas Nurse Leader Scholar at Columbia University School of Nursing 2012-2014. She has served on the National Institutes of Health, Healthcare Delivery and Methodologies, Special Emphasis Panel (July 2016) and the Centers for Disease Control and Prevention, Research on Technical Improvement of Personal Protective Equipment, Special Emphasis Panel (March 2016). Her research is funded by the Agency for Healthcare Research and Quality and she currently serves as co-investigator on two Agency grants. She recently served as a co-author on the CDC – American Nurses Association white paper entitled: Redefining the Antibiotic Stewardship Team: Recommendations from the American Nurses Association/Centers for Disease Control and Prevention Workgroup on the Role of Registered Nurses in Hospital Antibiotic Stewardship Practices.
Susan L. Davis, PharmD
Clinical Associate Professor
Eugene Applebaum College of Pharmacy and Health Sciences
Wayne State University, and
Infectious Diseases Pharmacy Specialist
Henry Ford Hospital
Click to view Dr. Davis' biography
Her primary research interests include strategies to improve outcomes of infectious diseases with a focus on antimicrobial stewardship and multidrug resistant bacteria. Her practice, teaching and research have been recognized with the Society of Infectious Disease Pharmacists Outstanding Clinical Practice award, the American Society of Health System Pharmacists Foundation New Preceptor of the Year award, and the Wayne State University College of Pharmacy and Health Sciences Research Excellence Award. She is a board member-at-large of SIDP and has been active in MAD-ID for over 10 years.
Thomas M. File, Jr., MD, MSc, MACP, FIDSA, FCCP
Chair, Infectious Disease Division
Summa Health System, Akron Ohio, and
Professor, Internal Medicine; Chair, Infectious Disease Section
Northeast Ohio Medical University
Click to view Dr. File's biography
Dr File is a Master of the American College of Physicians, a fellow and a past member of the Board of Directors of the Infectious Diseases Society of America (IDSA), and a fellow of the American College of Chest Physicians. He is President of the Board of Directors of the National Foundation for Infectious Diseases and is a member of many other professional societies, including the American Society for Microbiology, the American Thoracic Society (ATS) and the European Society of Clinical Microbiology and Infectious Diseases. He is a previous Chairperson of the Standards and Practice Guidelines Committee of the IDSA and has also served as a member of the IDSA and ATS committees for guidelines on community-acquired pneumonia; and is a member of the IDSA guidelines panels for hospital-acquired pneumonia, influenza and sinusitis. He is a past-president of the Infectious Disease Society of Ohio, and of the Northeastern Ohio Task Force on AIDS.
Primary research interests that Dr File has pursued include community-acquired respiratory tract infections, immunizations in adults, bacterial resistance in respiratory infections, infections in patients with diabetes, soft tissue infections, antimicrobial stewardship and evaluation of new antimicrobial agents. A frequent lecturer both nationally and internationally, Dr File has published more than 250 articles, abstracts and textbook chapters, focusing on the diagnosis, etiology and treatment of infectious diseases, and in particular, respiratory tract infections. He co-authored File TM Jr. and Stevens DL Contemporary Diagnosis and Management of Skin and Soft Tissue Infections,3rd Ed (2011, published by Handbooks in Health Care Co.) and co-edited Tan JS, File TM Jr., Salata RA, Tan MJ (eds.) Expert Guide to Infectious Diseases, 2nd edition (2008, published by ACP Press, Phil.). In addition, he is Editor-in-Chief of Infectious Diseases in Clinical Practice.
Debra A. Goff, PharmD, FCCP
Infectious Disease Specialist
Clinical Associate Professor
The Ohio State University Medical Center, Columbus, OH
Click to view Dr. Goff's biography
She is a member of the OSUMC Antimicrobial Stewardship Program, and is actively involved in developing strategies to control the escalating rate of antimicrobial resistance. The team manages both community-acquired and healthcare-associated infections. She recently developed a medical “app” called STAB-IT (Staph aureus bacteremia – is terrible) to help educate clinicians at OSUMC on the management of patients with Staph aureus bacteremia. Dr. Goff is the first medical educator to conduct a workshop on “Medical apps for Healthcare Professionals: Using the iPad to Educate”, at the Apple® store in Columbus, OH.
She has received numerous research grants and has lectured both nationally and internationally. Dr. Goff has published in several journals, including Clinical Infectious Diseases, Archives of Internal Medicine, Pharmacotherapy, Current Opinion in Infectious Diseases, and Journal of Infection.
Dr. Goff is an active member of Infectious Diseases Society of America, American College of Clinical Pharmacy, American Society for Microbiology, Society of Infectious Disease Pharmacists, and a board member of the National Foundation for Infectious Diseases. When she is not working, Dr. Goff can be found doing triathlons and photography.
Keith S. Kaye, MD, MPH, FIDSA, FSHEA, FACP
Professor of Medicine
University of Michigan Medical School
Ann Arbor, MI
Click to view Dr. Kaye's biography
Dr. Kaye’s particular clinical interests and skills are infections in the elderly, intravascular catheter-related infections, epidemiology of and outcomes associated with multidrug resistant bacteria, risk adjustment, prevention, risk factors and outcomes related to surgical site infections and infected prosthetic devices, antimicrobial resistance and infection control issues in community hospitals and tertiary care hospitals, and antimicrobial stewardship.
His principle research areas of interest include hospital-acquired infections, hospital epidemiology, infections in the elderly, antimicrobial resistance, surgical site infection, bloodstream infection, and antibiotic utilization. He is currently studying hospital-acquired infections in the elderly with partial funding for a career development grant from the National Institutes of Health.
Dr. Kaye has authored over 60 peer-reviewed articles and 5 book chapters and has presented numerous abstracts at national conferences.
Kerry L. LaPlante, PharmD., FCCP, FIDSA
Professor of Pharmacy, University of Rhode Island, Kingston, RI
Adjunct Professor of Medicine, Brown University, Providence, RI
Click to view Dr. LaPlante's biography
Kerry LaPlante, Pharm.D., FCCP is a tenured Professor of Pharmacy at the University of Rhode Island, an Adjunct Professor of Medicine at Brown University, and the Founding Director of the Antimicrobial Stewardship Research Fellowship at the Providence Veterans Medical Center. Her work is dedicated to furthering antibiotic education and research across the full spectrum of healthcare science, from antibiotic development to clinical applications. An underlying hypothesis in Dr. LaPlante’s research is that implementing positive change in prescriber habits will occur through communication, trust, personalized education, and highlighting the safety and public health benefit to their patients and their local community. Most recently, her research has focused on the development of public health messaging and trust in desperate patient populations, along with implementing antimicrobial stewardship programs in acute care, and long-term care patient populations across the VA nationally.
Dr. LaPlante’s clinical and research career has been focused on identifying effective and safe treatments for antimicrobial resistance pathogens and, more specifically on the impact that antimicrobial prescribing and stewardship has on the emergence and spread of antimicrobial resistance. Dr. LaPlante also directs active in vitro research program (BSL-2) that explores pharmacodynamic dosing indexes of combination antibiotic therapy in pathogenic bacteria, specifically the treatment, virulence inhibition (toxin and biofilm), colonization and control of multiply drug resistant pathogens in catheter lock solutions.
Dr. LaPlante has maintained continuous uninterrupted funding for her in vitro and outcomes research program from both public and private sources since arriving at the university in 2004. Her award-funding total is over 12 million from agencies such as National Institutes of Health, Department of Veterans Affairs, and Investigator Initiated Research at Pfizer, Merck and other Research and Development based pharmaceutical companies.
An internationally recognized leader in the field of antibiotic research, Dr. LaPlante is an elected Fellow of the American College of Clinical Pharmacy, and president-elect of the Society of Infectious Diseases Pharmacists, and appointed Vice-Chairperson of the Rhode Island Department of Health Antimicrobial Stewardship and Environmental Cleaning Task Force, and has served on the editorial boards for the leading journals in pharmacy and pathogenic microbiology (including Pharmacotherapy and Virulence). She is also the recipient of the Rhode Island Society of Health-System Pharmacists, 2016 Pharmacist of the Year and the Society of Infectious Diseases Pharmacist Researcher of the year 2010. She is frequently invited to lecture at national infectious diseases meetings and symposia, and is an author on over 80 peer-reviewed articles, and book chapters, which span topics from antimicrobial stewardship, antibiotic resistance, drug discovery and in vitro activity of combination antimicrobial agents. She is also the senior editor of a book titled “Antimicrobial Stewardship Principles and Practices” which is currently in press and available at Amazon.
Jason Newland, MD, EdD
Associate Professor of Pediatrics
Washington University School of Medicine in St. Louis, MO
Click to view Dr. Newland's biography
Dr. Newland grew up in southwest Oklahoma, and obtained his B.S. in Pre-professional studies at the University of Notre Dame in 1996 and medical degree from the University of Oklahoma College of Medicine in 2000. He completed pediatric residency at the University of Nebraska/Creighton Medical Centers in 2003 and fellowship in Pediatric infectious diseases at the Children’s Hospital of Philadelphia in 2006, distinguishing himself with teaching awards at both the resident and fellow level.
In August of 2006, he joined the faculty at Children’s Mercy Hospitals & Clinics in Kansas City, Missouri where he was the director of the antimicrobial stewardship program and the director of evidence-based practice. An active resident and faculty mentor, he has also completed his master’s in education through a joint program offered by the Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Education, focusing on adult learning, curriculum and teaching methods, and medical education evaluation and research. He is currently Associate Professor of Pediatrics at Washington University School of Medicine in St. Louis.
His current research spotlights the use of antimicrobials and the impact of an antimicrobial stewardship program at a children’s hospital. Additionally, he is interested in the impact of clinical practice guidelines on the care of children. Finally, he has developed mobile apps to further enhance the delivery of guidelines to the practicing clinician.
Michael J. Rybak, PharmD, MPH, PhD, FCCP
Associate Dean for Research
Professor of Pharmacy and Medicine
Director, Anti-Infective Research Laboratory
Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI
Click to view Dr. Rybak's biography
Dr. Rybak is Associate Dean for Research and Professor of Pharmacy at the Eugene Applebaum College of Pharmacy and Health Sciences (EACPHS). He is also an Adjunct Professor of Medicine in the Division of Infectious Diseases at the School of Medicine at Wayne State University in Detroit, Michigan. Dr. Rybak is Director of the Anti-Infective Research Laboratory at EACPHS, and is affiliated with Detroit Receiving Hospital and University Health Center.
He received his undergraduate degree in Pharmacy from Northeastern University in Boston, Massachusetts, his PharmD from the College of Pharmacy and Health Sciences, and his MPH from the School of Medicine at Wayne State University.
Dr. Rybak’s primary research focus is antimicrobial pharmacokinetics and pharmacodynamics (PK/PD) and their relationship to bacterial resistance. He has published several book chapters and numerous articles in scientific journals on topics such as antimicrobial PK/PD and resistance to antimicrobial agents, the importance of bactericidal drugs, and the assessment of patient outcome as it relates to antimicrobial resistance issues. Dr. Rybak is the Scientific Field Editor for the Infectious Diseases section of Pharmacotherapy, and serves as an editorial reviewer for a number of other scientific publications.
He is a member of several professional societies, including the American College of Clinical Pharmacy, the American Society of Health-System Pharmacists, the Society of Infectious Diseases Pharmacists, the American Society for Microbiology, and the Infectious Diseases Society of America.
Edward J. Septimus, MD, FIDSA, FACP, FSHEA
Texas A&M Medical School
Click to view Dr. Septimus' biography
Dr. Ed Septimus received his medical degree from Baylor College of Medicine in Houston in 1972. Dr. Septimus went on to complete his postgraduate training in internal medicine and infectious diseases at Baylor College of Medicine in Houston. Dr. Ed Septimus is board certified in both internal medicine and infectious diseases.
He was VP Research and Infectious Diseases Hospital Corporation of America (HCA). He has served on the Board of Directors of the Infectious Diseases Society of America (IDSA) and was on the IDSA Antimicrobial Resistance Committee, the SHEA Antimicrobial Stewardship Committee, and the IDSA Quality Measurement Committee. He was the first recipient of the IDSA Annual Clinician Award. In 2011 he was appointed to the Healthcare-Associated Infections/Preventable Adverse Events Advisory Panel for the Texas Department of State Health Services. He was awarded the John S Dunn Sr. Outstanding Teacher Award in 2010, 2011, 2013, 2014, and 2016. He is on the FDA Anti-Infective Drug Advisory Group and is co-chair of the NQF Patient Safety Steering Committee.
He holds a faculty position as Clinical Professor at Texas A&M Medical School and Professor, Distinguished Senior Fellow, School of Public Health, George Mason University and Senior Lecturer Department Population Medicine Harvard Medical School. He has published over 100 articles and chapters.